3 excellent ASX shares I would buy and hold for 10 years or more

I think these three businesses still have plenty of room to grow over the next decade.

Some businesses make me comfortable looking well beyond the next year or two.

I think the three ASX shares below have strong positions in their markets and clear ways to keep growing for many years.

Here is why they would be on my long-term buy list.

Shot of a young businesswoman using her phone at work, with stock market related images in the background.

Image source: Getty Images

REA Group Ltd (ASX: REA)

REA Group owns one of the most powerful digital platforms in Australia through realestate.com.au.

People looking to buy, sell, or rent property naturally want to use the website with the most listings. At the same time, property agents want to advertise where the largest audience is searching.

I think that gives REA Group a strong competitive position that would be difficult to replicate.

There is also more to the opportunity than simply attracting property listings.

REA Group can keep improving the tools available to buyers, sellers, and agents, including property data, personalised recommendations, and artificial intelligence. It can also build closer relationships with people as they move through the property journey, including when they need financing.

Australia should continue adding people and homes over the long term, giving REA Group an expanding market to serve.

For me, the combination of a powerful brand, enormous audience, and opportunities to make the platform more valuable makes REA Group a business I would be comfortable owning for many years.

SiteMinder Ltd (ASX: SDR)

Another ASX share I would buy and hold is SiteMinder. It gives hotels the technology they need to sell rooms and manage their presence across online booking channels.

I like the long-term opportunity because the global accommodation market remains highly fragmented.

Large hotel chains may have substantial technology budgets, but there are countless independent hotels and smaller accommodation providers that still need better ways to manage pricing, bookings, distribution, and guest relationships.

SiteMinder can bring many of those functions together through one platform.

I also like that the company has been expanding what its technology can do. Products such as Channels Plus and Dynamic Revenue Plus are designed to help hotels reach more travellers and make better pricing decisions.

Artificial intelligence could make those tools even more valuable by helping hotel operators automate more of the work involved in managing rooms and responding to changing demand.

If SiteMinder can keep adding properties while increasing the amount of technology each customer uses, I think the business could have a long growth runway ahead.

ResMed Inc (ASX: RMD)

ResMed is an ASX share operating in an area of healthcare where I think demand could continue expanding for decades.

The company develops devices and masks used to treat sleep apnoea, a condition affecting a huge number of people worldwide.

What I like is that the relationship with a patient can continue well beyond the initial sale of a device.

Masks and other components need replacing, while ResMed's digital platforms can help patients and healthcare providers manage treatment over time.

That creates an opportunity to keep serving existing patients while also reaching people who have yet to be diagnosed or treated.

Greater awareness of sleep health could help with that. Improvements in diagnosis and easier access to treatment could bring more people into the market over the years ahead.

Foolish takeaway

The businesses I most enjoy owning are those where I can see several ways for the company to be stronger five or 10 years from now.

For me, REA Group, SiteMinder, and ResMed are three shares I would be happy to hold patiently for the long term.

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed and SiteMinder. The Motley Fool Australia has positions in and has recommended ResMed and SiteMinder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

A young farnmer raise his arms to the sky as he stands in a lush field of wheat or farmland.
Growth Shares

PLS Group vs Zip: Which ASX share could be a 10-bagger?

Which of PLS Group and Zip is better positioned to deliver truly explosive long-term returns? Here’s my candid take for…

Read more »

Happy girl holding a plant and soil in front of ascending piles of coins.
Growth Shares

3 ASX 200 shares I think could rise more than 10% in a year

I think these three ASX shares have enough going for them to outperform over the next 12 months.

Read more »

Two colleagues looking at a graph and comparing share prices.
Growth Shares

These 3 ASX shares have the ingredients of long-term compounders

These shares could be well-positioned for growth in the future. Let's see why.

Read more »

Red buy button on an Apple keyboard with a finger on it.
Growth Shares

2 ASX shares highly recommended to buy: Experts

Experts are loving the excitement of these stocks.

Read more »

Hour glass next to pile of coins and notes.
Growth Shares

2 top ASX shares to buy and hold for the next decade

These investments have very exciting futures.

Read more »

a graph indicating escalating results
Growth Shares

A rare buying opportunity in 1 of Australia's top shares?

I think this is a great time to invest in this stock…

Read more »

A financial expert or broker looks worried as he checks out a graph showing market volatility.
Growth Shares

A leading fund just bought these top ASX 200 shares

These stocks could be top buys today…

Read more »

Man with hand to his forehead looking at his laptop.
Growth Shares

Droneshield vs Zip Co: Which tech share is the better ASX growth pick?

I unpack Droneshield vs Zip shares to reveal which ASX tech stock looks better for growth-focused investors right now.

Read more »